Evogene Ltd
NASDAQ:EVGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evogene Ltd
NASDAQ:EVGN
|
IL |
|
L
|
Linkers Industries Ltd
NASDAQ:LNKS
|
MY |
|
I
|
Ipopema Securities SA
WSE:IPE
|
PL |
|
Greenbrook TMS Inc
TSX:GTMS
|
CA |
|
H
|
Health-Chem Corp
OTC:HCLC
|
US |
Wall Street
Price Targets
EVGN Price Targets Summary
Evogene Ltd
According to Wall Street analysts, the average 1-year price target for
EVGN
is 1.79 USD
with a low forecast of 1.77 USD and a high forecast of 1.84 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EVGN's stock price target?
Price Target
1.79
USD
According to Wall Street analysts, the average 1-year price target for
EVGN
is 1.79 USD
with a low forecast of 1.77 USD and a high forecast of 1.84 USD.
What is Evogene Ltd's Revenue forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Evogene Ltd's revenue is
-9%.
The projected
CAGR
for the next 3 years is
9%.